1. Home
  2. TLSA vs AOMR Comparison

TLSA vs AOMR Comparison

Compare TLSA & AOMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.37

Market Cap

192.1M

Sector

Health Care

ML Signal

HOLD

AOMR

Angel Oak Mortgage REIT Inc.

HOLD

Current Price

$8.94

Market Cap

218.7M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLSA
AOMR
Founded
2013
2018
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
192.1M
218.7M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
TLSA
AOMR
Price
$1.37
$8.94
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$11.25
AVG Volume (30 Days)
342.9K
69.7K
Earning Date
05-06-2025
03-03-2026
Dividend Yield
N/A
14.33%
EPS Growth
N/A
N/A
EPS
N/A
0.73
Revenue
N/A
$34,705,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$17.06
P/E Ratio
N/A
$12.18
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$7.36
52 Week High
$2.60
$10.88

Technical Indicators

Market Signals
Indicator
TLSA
AOMR
Relative Strength Index (RSI) 35.75 46.46
Support Level $1.25 $8.76
Resistance Level $1.77 $9.07
Average True Range (ATR) 0.11 0.16
MACD -0.03 -0.04
Stochastic Oscillator 5.77 17.31

Price Performance

Historical Comparison
TLSA
AOMR

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About AOMR Angel Oak Mortgage REIT Inc.

Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation across interest rates and credit cycles.

Share on Social Networks: